Guy Las
Research Subjects
Research Interests
Guy Las has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anton Petcherski
Department of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, USA
1 shared publication Boris M. Baranovski
Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501 Israel
1 shared publicationDane Wolf
Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-7073, U.S.A.
1 shared publicationEli C. Lewis
Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501 Israel
1 shared publicationEssam A. Assali
Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-7073, U.S.A.
1 shared publicationFernanda M. Cerqueira
National Institute for Biotechnology in the Negev, Ben Gurion University, Beer-Sheva 8410501, Israel
1 shared publication
Latest Publications
- 31 January 2020
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 477 (2) , 461-475
MitoTimer-based high-content screen identifies two chemically-related benzothiophene derivatives that enhance basal mitophagy
Mitochondrial turnover is required for proper cellular function. Both mitochondrial biogenesis and mitophagy are impaired in several degenerative and age-related diseases. The search for mitophagy activators recently emerged as a new therapeutical approach; however, there is a lack in suitable tools to follow mitochondrial turnover in a high-throughput manner. We demonstrate that the fluorescent protein, MitoTimer, is a reliable and robust probe to follow mitochondrial turnover. The screening of 15 000 small molecules led us to two chemically-related benzothiophenes that stimulate basal mitophagy in the beta-cell line, INS1. Enhancing basal mitophagy was associated with improved mitochondrial function, higher Complex I activity and Complex II and III expressions in INS1 cells, as well as better insulin secretion performance in mouse islets. The possibility of further enhancing mitophagy in the absence of mitochondrial stressors points to the existence of a ‘basal mitophagy spare capacity'. To this end, we found two small molecules that can be used as models to better understand the physiological regulation of mitophagy.
- 31 January 2020
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 477 (2) , 461-475
MitoTimer-based high-content screen identifies two chemically-related benzothiophene derivatives that enhance basal mitophagy
Mitochondrial turnover is required for proper cellular function. Both mitochondrial biogenesis and mitophagy are impaired in several degenerative and age-related diseases. The search for mitophagy activators recently emerged as a new therapeutical approach; however, there is a lack in suitable tools to follow mitochondrial turnover in a high-throughput manner. We demonstrate that the fluorescent protein, MitoTimer, is a reliable and robust probe to follow mitochondrial turnover. The screening of 15 000 small molecules led us to two chemically-related benzothiophenes that stimulate basal mitophagy in the beta-cell line, INS1. Enhancing basal mitophagy was associated with improved mitochondrial function, higher Complex I activity and Complex II and III expressions in INS1 cells, as well as better insulin secretion performance in mouse islets. The possibility of further enhancing mitophagy in the absence of mitochondrial stressors points to the existence of a ‘basal mitophagy spare capacity'. To this end, we found two small molecules that can be used as models to better understand the physiological regulation of mitophagy.